Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Community Oncology Alliance Names Dr. Frederick M. Schnell to Newly Created Medical Director Position

Community Oncology Alliance
Posted on: 22 Feb 18
Community Oncology Alliance Names Dr. Frederick M. Schnell to Newly Created Medical Director Position Experienced Community Oncologist Will Provide Valuable Guidance on Patient Care and Practice Operations

PR Newswire

WASHINGTON, Feb. 22, 2018

WASHINGTON, Feb. 22, 2018 /PRNewswire-USNewswire/ -- The Community Oncology Alliance (COA) announced today that Frederick M. Schnell, M.D., F.A.C.P., has been appointed to the newly created staff position of Medical Director. He brings more than three decades of experience as a physician and community oncology practice CEO. Among the first issues Dr. Schnell will help community oncology practices address is the future of oncology payment reform.

Previously, Dr. Schnell was a practicing community oncologist for 34 years, most recently as CEO, at Central Georgia Cancer Care in Macon, Ga. He is also currently a Clinical Asssitant Professor, Department of Medicine, Mercer Uiversity School of Medcine, Macon, Ga. and a Clinical Assistant Professor of Hematology and Oncology at the Winship Cancer Institute, Emory University School of Medicine, Atlanta, Ga. Dr. Schnell has been the recipient of the Distinguished Cancer Clinician Award from the Georgia Cancer Coalition. He was a founding physician of COA, served as the third COA president, and as a member of the COA Board of Directors for many years.

"This position is coming back to a 'family' I know well," said Dr. Schnell. "This is a crucial time for community oncology. There are obstacles and issues to be sure, but the future is so much more positive and COA has more resources than at any time in its history."

"We are pleased to have Dr. Schnell joining the Community Oncology Alliance team. His years of practice, patient care and an intimate understanding of the issues facing cancer care providers and cancer patients make Dr. Schnell perfectly suited to be our Medical Director," said Jeff Vacirca, MD, CEO of NY Cancer Specialists in New York and president of COA. "The rapidly changing landscape of cancer care delivery in the United States demands insight like his to craft the future strategies for community oncology."

Dr. Schnell's full biography is available on the COA website at

About the Community Oncology Alliance:  COA is a non-profit organization dedicated to advocating for community oncology practices and, most importantly, the patients they serve. COA is the only organization dedicated solely to independent community oncology where the majority of Americans with cancer are treated. The mission of COA is to ensure that cancer patients receive quality, affordable, and accessible cancer care in their own communities. For more than 15 years, COA has built a national grassroots network of community oncology practices to advocate for public policies that benefit cancer patients.

To learn more about COA, visit .
Follow COA on Twitter at  
Follow COA on Facebook at .

View original content with multimedia:

SOURCE Community Oncology Alliance

PR Newswire

Last updated on: 22/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.